Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Digital Image Hub Integrated with Whole-Slide Informatics Solutions

By LabMedica International staff writers
Posted on 01 Sep 2011
An integrated digital pathology software offering will allow those using image analysis and stereology in digital pathology to achieve a streamlined workflow.

Leica Microsystems' (Wetzlar, Germany) SlidePath digital image hub is being integrated with Visiopharm's (Medicon Valley, Denmark) whole-slide informatics solutions. More...
Users can now take advantage of superior image capture and management from Leica Microsystems and excellent Whole Slide image analysis and Whole Slide Stereology from Visiopharm in a single system.

All images stored on the Digital Image Hub server can be browsed and accessed via the Visiopharm software. Selected images are then easily opened and analyzed by either Visiopharm’s image analysis software or stereology software. Following analysis, users can quickly view the resulting data and associated slides through the Visiopharm software interface.

Leica’s Digital Image Hub, developed by SlidePath, is a scalable enterprise-level solution for the management and archiving of digital slides and associated data. The Digital Image Hub is accessed via a standard internet browser and supports images from a variety of digital slide scanners.

The Stavanger University Hospital (Norway) has chosen Leica Microsystems’ Total Digital Pathology solution for scanning and storage of digital slides, and the Visiopharm solution for image analysis.

Dr. Kjell H Kjellevold, head of the hospital's pathology department said, “For us, the combination of these two systems is ideal. The speed and image quality of the Leica SCN400 slide scanner combined with the Digital Image Hub management solution is exactly what is required for making Digital Pathology feasible for research work. The image analysis software from Visiopharm consolidates simplicity for routine work and the flexibility for research. This, together with the low costs of learning and computation, was critical for our decision.”

Related Links:
Leica Microsystems
Visiopharm
Stavanger University Hospital


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gel Cards
DG Gel Cards
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.